Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography

被引:148
|
作者
Patel, Parag [1 ]
Dhillon, Ashwat [1 ]
Popovic, Zoran B. [1 ]
Smedira, Nicholas G. [1 ]
Rizzo, Jessica [1 ]
Thamilarasan, Maran [1 ]
Agler, Deborah [1 ]
Lytle, Bruce W. [1 ]
Lever, Harry M. [1 ]
Desai, Milind Y. [1 ]
机构
[1] Cleveland Clin, Inst Heart & Vasc, Hypertroph Cardiomyopathy Ctr, Cleveland, OH 44195 USA
关键词
cardiomyopathy; hypertrophic; echocardiography; magnetic resonance imaging; mitral valve; multimodal imaging; papillary muscles; surgery;
D O I
10.1161/CIRCIMAGING.115.003132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In patients with hypertrophic cardiomyopathy and left ventricular outflow tract (LVOT) obstruction, but without basal septal hypertrophy, we sought to identify mitral valve (MV) and papillary muscle (PM) abnormalities that predisposed to LVOT obstruction, using echo and cardiac magnetic resonance. Methods and Results-We studied 121 patients with hypertrophic cardiomyopathy hypertrophic cardiomyopathy (age, 49 +/- 17 years; 60% men; 57% on beta-blockers) with a basal septal thickness of <= 1.8 cm who underwent echocardiography (rest+stress) and cine cardiac magnetic resonance. Echo measurements included maximal LVOT gradient (rest/provocable), MV leaflet length (parasternal long, 4 and 3-chamber views), and abnormal chordal attachment to mid/base of anterior MV. Cine cardiac magnetic resonance measurements included basal septal thickness, number/area of PM heads, and bifid PM mobility (in systole and diastole). Mean basal septal thickness, LVOT gradient, and LV ejection fraction were 1.5 +/- 0.3 cm, 72 +/- 54 mm Hg, and 61 +/- 6%, respectively. The number of anterolateral and posteromedial PM heads was 2.7 +/- 0.7 and 2.6 +/- 0.7, respectively. Anterolateral and posteromedial PM areas were 19.9 +/- 7 cm(2) and 17.1 +/- 6 cm(2), respectively. PM mobility was 11 +/- 6 degrees. On multivariable analysis, predictors of maximal LVOT gradient were basal septal thickness, bifid PM mobility, anterior mitral leaflet length, and abnormal chordal attachment to base of anterior mitral leaflet. Forty-five patients underwent surgery to relieve LVOT obstruction, of which 52% needed an additional nonmyectomy (MV repair/replacement or PM reorientation) approach. Conclusions-In hypertrophic cardiomyopathy patients without significant LV hypertrophy, in addition to basal septal thickness, anterior MV length, abnormal chordal attachment, and bifid PM mobility are associated with LVOT obstruction. In such patients, additional procedures on MV and PM (+/- myectomy) could be considered.
引用
收藏
页数:10
相关论文
共 33 条
  • [31] Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging
    Kobayashi, Hitomi
    Kobayashi, Yasuyuki
    Giles, Jon T.
    Yoneyama, Kihei
    Nakajima, Yasuo
    Takei, Masami
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (10) : 1916 - 1921
  • [32] Assessment of Left Ventricular Mass in Hypertrophic Cardiomyopathy Patients Bb Real-Time 3-Dimensional Echocardiography in Single-Beat Capture Image; Validation with Cardiac Magnetic Resonance Imaging
    Chang, Sung-A
    Lee, Sang-Chol
    Kim, Eun-Young
    Hahm, Seung-Hee
    Sohn, Myung-Kyun
    Kim, Eun-Young
    Park, Sung-Ji
    Choi, Jin-Oh
    Hahn, Joo-Yong
    Park, Seung Woo
    Choe, Yeon Hyeon
    Oh, Jae K.
    CIRCULATION, 2011, 124 (21)
  • [33] Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT), and Brugada syndrome (BrS)
    Heermann, Philipp
    Fritsch, H.
    Koopmann, M.
    Sporns, P.
    Paul, M.
    Heindel, W.
    Schulze-Bahr, E.
    Schuelke, C.
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (10) : 1147 - 1162